Irska - engleski - HPRA (Health Products Regulatory Authority)

stravencon ltd - cefuroxime sodium - powder for solution for injection - 750 milligram(s) - second-generation cephalosporins; cefuroxime

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

sagent pharmaceuticals - cefuroxime sodium (unii: r8a7m9my61) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 750 mg - cefuroxime for injection, usp is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: - lower respiratory tract infections , including pneumonia, caused by streptococcus pneumoniae, haemophilus influenzae (including ampicillin-resistant strains), klebsiella spp., staphylococcus aureus (penicillinase- and non-penicillinase- producing strains), streptococcus pyogenes , and escherichia coli . - urinary tract infections caused by escherichia coli and klebsiella spp. - skin and skin structure infections caused by staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), streptococcus pyogenes , escherichia coli, klebsiella spp., and enterobacter spp. - septicemia caused by staphylococcus aureus (penicillinase- and non-penicillinase- producing strains), streptococcus pneumoniae, escherichia coli, haemophilus influenzae (including ampicillin-resistant strains), and klebsiella spp. - men

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - cefuroxime sodium (unii: r8a7m9my61) (cefuroxime - unii:o1r9fj93ed) - cefuroxime for injection, usp is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: - lower respiratory tract infections, including pneumonia, caused by streptococcus pneumoniae, haemophilus influenzae (including ampicillin-resistant strains), klebsiella spp., staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), streptococcus pyogenes, and escherichia coli. - urinary tract infections caused by escherichia coli and klebsiella spp. - skin and skin-structure infections caused by staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), streptococcus pyogenes , escherichia coli , klebsiella spp., and enterobacter spp. - septicemia caused by staphylococcus aureus (penicillinase- and non-penicillinase producing strains), streptococcus pneumoniae, escherichia coli, haemophilus influenzae (including ampicillin-resistant strains), and klebsiella spp. - meningitis caused

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - cefuroxime sodium (unii: r8a7m9my61) (cefuroxime - unii:o1r9fj93ed) - cefuroxime for injection, usp is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: - lower respiratory tract infections , including pneumonia, caused by streptococcus pneumoniae , haemophilus influenzae (including ampicillin-resistant strains), klebsiella spp., staphylococcus aureus (penicillinase- and non–penicillinase-producing strains), streptococcus pyogenes , and escherichia coli . - urinary tract infections caused by escherichia coli and klebsiella spp. - skin and skin­-structure infections caused by staphylococcus aureus (penicillinase- and non–penicillinase-producing strains), streptococcus pyogenes , escherichia coli , klebsiella spp., and enterobacter spp. - septicemia caused by staphylococcus aureus (penicillinase- and non–penicillinase-producing strains), streptococcus pneumoniae , escherichia coli , haemophilus influenzae (including ampicillin-resistant strains), and klebsiella spp. - m

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - cefuroxime sodium (unii: r8a7m9my61) (cefuroxime - unii:o1r9fj93ed) - cefuroxime for injection, usp is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: - lower respiratory tract infections, including pneumonia, caused by streptococcus pneumoniae, haemophilus influenzae (including ampicillin-resistant strains), klebsiella spp., staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), streptococcus pyogenes, and escherichia coli. - urinary tract infections caused by escherichia coli and klebsiella spp. - skin and skin-structure infections caused by staphylococcus aureus (penicillinase- and non-penicillinase-producing strains), streptococcus pyogenes , escherichia coli , klebsiella spp., and enterobacter spp. - septicemia caused by staphylococcus aureus (penicillinase- and non-penicillinase producing strains), streptococcus pneumoniae, escherichia coli, haemophilus influenzae (including ampicillin-resistant strains), and klebsiella spp. - meningitis caused

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cefuroxime sodium 1537mg equivalent to 1500 mg cefuroxime anhydrous;   - powder for injection - 1500 mg - active: cefuroxime sodium 1537mg equivalent to 1500 mg cefuroxime anhydrous  

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cefuroxime sodium 256mg equivalent to 250 mg cefuroxime anhydrous;   - powder for injection - 250 mg - active: cefuroxime sodium 256mg equivalent to 250 mg cefuroxime anhydrous  

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cefuroxime sodium 769mg equivalent to 750 mg cefuroxime anhydrous;   - powder for injection - 750 mg - active: cefuroxime sodium 769mg equivalent to 750 mg cefuroxime anhydrous  

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

hospira nz ltd - cefuroxime sodium 1578mg equivalent to 1500 mg cefuroxime - powder for injection - 1500 mg - active: cefuroxime sodium 1578mg equivalent to 1500 mg cefuroxime

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

hospira nz ltd - cefuroxime sodium 263mg equivalent to 250 mg cefuroxime - powder for injection - 250 mg - active: cefuroxime sodium 263mg equivalent to 250 mg cefuroxime